Management of skin toxicities during panitumumab treatment in metastatic colorectal cancer.

<h4>Background</h4>Anti-epidermal growth factor receptor therapy is associated with skin adverse events not previously reported with conventional chemotherapy. Prophylactic actions are recommended, but routine clinical management of these toxicities and their impact on quality of life remain unknown... View More